HiSiaddi is an innovative foreign trade service provider driven by both technology commercialization and foreign trade services, with a "1+2+3+4=1" service system and access to original L-valine raw materials from multiple well-known manufacturers.
As a foreign trade enterprise with independent R&D capabilities, HiSiaddi has repeatedly proposed formula optimization solutions and application improvement suggestions for L-valine raw materials through technology cooperation with manufacturers and precise market insight. Below is a consulting case of HiSiaddi’s L-valine raw material formula optimization services.
For more formula optimization consulting services, please contact HiSiaddi customer service.
Purchaser: NaturaPet, a high-end therapeutic pet food group headquartered in Helsinki, Finland, a leading Nordic developer of prescription pet food. Its product portfolio focuses on nephropathy prescription diets, post-operative recovery liquid rations and complete specialized diets for breeding young pets. Products comply with EU FEDIAF pet feed standards, Finnish national food regulations and EFSA additive control specifications, and are exclusively supplied to high-end Nordic pet pharmacy chains and private animal clinics. The group has long sourced pharmaceutical-grade L-valine from Kyowa Hakko (Japan), with stable annual L-valine procurement of 112 tons.
To optimize supply chain costs, the client purchased bulk domestic standard food-grade L-valine. After raw material warehousing and commissioning, systematic technical failures occurred on two core production lines: low-temperature wet extrusion granulation and automatic powder mixing. Consequences included unbalanced finished product nutrition, cracked coating during granulation, moisture absorption and caking during storage, and substandard intestinal absorption rates of prescription pet food, halting mass production of new products with a finished product rejection rate as high as 35%. Domestic suppliers only monitor basic national standard content indicators and lack familiarity with EU prescription pet food formula logic and automated production working conditions, making them unable to conduct comprehensive troubleshooting and rectification covering raw material modification, formula adjustment and workshop processes. The client formally entrusted HiSiaddi’s technical foreign trade team to fully diagnose issues and deliver a complete technical optimization solution.
The client’s two core production lines: ① Nephropathy extruded prescription food (valine + branched-chain amino acid compound formula); ② Post-operative liquid filling powder (carrier-free clean formula).
Conventional domestic L-valine is ultra-fine powder of 80–120 mesh with a repose angle over 46°, causing bridging and blockages in silo feeding and frequent mixer shutdowns for cleaning. Fine powder floats to the upper layer of the formula, resulting in 30% excess valine in partial batches and insufficient content in others, failing Finnish food authority inspections for nutritional uniformity. Root Cause: Domestic manufacturers adopt crude crystallization and standard crushing processes without graded granulation, producing generic fine powder without particle modification tailored to automatic premix production lines.
Residual fermentative organic acid by-products in raw materials undergo neutralization reactions with calcium carbonate and calcium hydrogen phosphate mineral additives in formulas. Finished products harden and cake after 45 days of ambient storage, with valine effective content declining by 8.8%, failing the EU mandatory 24-month shelf-life requirement. Root Cause: Fermentation broth only undergoes a single simple recrystallization post-concentration, lacking multi-stage pure water refining to remove by-products and free acidic substances; internal control standards only align with national benchmarks.
The client’s extrusion granulation section operates at 72–78°C. Uncoated standard L-valine partially decomposes under heat, reducing animal intestinal absorption rates from the 89% benchmark of imported raw materials to 67%, rendering nephropathy prescription food ineffective in clinical feeding trials. Root Cause: Raw materials lack protective coating modification; standard domestic uncoated products are only suitable for ambient-temperature dry powder blending, incompatible with extrusion granulation working conditions.
Heavy metal and mold indicators of domestic raw materials sit close to national standard upper limits. Retaining the original formula addition ratios designed for Japanese raw materials leads to cumulative excess of multiple trace elements, risking product removal from shelves.
1. Refining & Purification Optimization: HiSiaddi coordinated manufacturers to optimize post-fermentation processes by adding two-stage countercurrent pure water rinsing and secondary gradient cooling recrystallization to remove fermentative by-products and free organic acids, reducing acidic impurities below 0.1% and eliminating acid-base reaction triggers in downstream formulas.
2. Particle Granulation Modification: Deploy wet roll granulation and graded screening to produce uniform 20–40 mesh granules, controlling powder repose angle within 36° and reducing fine powder proportion below 1%, completely resolving feeding blockages and mixing stratification in automated production.
3. Low-Temperature Plant-Based Coating Modification: Adopt EU-approved refined palm oil low-temperature micro-encapsulation to form a protective layer. Valine decomposition loss is less than 5% under short-term 78°C granulation conditions, drastically improving thermal stability. Industrial mineral oil coating is discarded to meet the client’s clean organic labeling requirements.
4. Strict Control of Safety Indicators: Optimize fermentation raw materials and workshop cleanliness control, with packaging conducted in Class 100,000 clean workshops. Total aerobic count and heavy metals are controlled per Finnish FEDIAF standards, with indicators more stringent than national standards by over 100%.
1. Nephropathy Extruded Prescription Food Formula Optimization: Utilize low-impurity modified L-valine to reduce calcium carbonate buffer salt addition by 21% and minimize acid-base buffer components in the system. Adjust raw material feeding ratios based on the measured biological potency of modified valine, and optimize the proportional balance of leucine, isoleucine and valine (branched-chain amino acids) to the optimal ratio for Nordic nephropathic cat and dog amino acid metabolism.
2. Post-Operative Liquid Powder Formula Optimization: Raw materials are pre-sieved for impurity removal before feeding. Food-grade plant-derived silica (compliant anti-caking agent eligible for EU all-vegetarian labeling) is added to formulas to improve powder dispersion without allergenic exogenous auxiliary materials.
1. Environmental Control: Raw material unpacking and premixing workshops maintain a constant temperature of 21°C and relative humidity below 40% to isolate raw materials from moisture absorption and caking after opening.
2. Stepwise Dilution Premixing Feeding: Adopt stepwise dilution premixing for trace raw materials. Valine is pre-mixed at low speed with 5 times its weight of carrier auxiliary materials for 15 minutes before full blending with bulk main materials to enhance material uniformity.
3. Segmented Temperature Control During Granulation: Lower temperature in the conditioning section by 5°C and shorten raw material high-temperature exposure duration to reduce coating breakage risks.
1. Accelerated Stability Testing: Finished products manufactured with optimized raw materials undergo 90-day constant-temperature accelerated storage at 40°C, showing no caking or excessive loss of active ingredients, with physicochemical indicators meeting Finnish food authority standards.
2. 800kg Full-Line Pilot Production: Continuous full-line operation without feeding blockages, finished product defect rate reduced from 35% to 0.6%.
3. Animal Feeding Trials: 28-day feeding trials with nephropathic dogs at partner animal hospitals restore L-valine intestinal absorption rate to 87.5%, matching the performance of imported raw materials.
1. For Finnish NaturaPet Group: Successfully completed localized replacement of Japanese imported valine, cutting comprehensive raw material procurement costs by 30.2%. Two core prescription pet food lines launched on schedule across high-end Nordic pet pharmacies, with growing distribution orders in Sweden and Norway within six months of launch. Annual procurement volume rose from 112 tons to 136 tons.
2. For Domestic Manufacturers: The benchmark Nordic high-end order standardized production processes for low-impurity granular heat-resistant coated high-grade valine. Export unit prices for customized premium grades carry a 38% premium over standard feed-grade valine, with trial sample orders secured from two mid-to-high-end pet food enterprises in Denmark and Iceland.
3. For HiSiaddi Foreign Trade: Established a full-chain amino acid technical service system covering raw material process defect diagnosis, upstream fermentation and refining renovation, downstream formula calibration and on-site production standardization, continuously undertaking technical rectification projects for mid-to-high-end nutritional raw materials in Northern and Western Europe.
The vast majority of domestic L-valine manufacturers focus on mass production of generic feed-grade products with fixed fermentation, crystallization and post-treatment processes. Their product indicators only meet domestic national standards, lacking understanding of sophisticated EU therapeutic pet food formula systems and automated high-temperature granulation production characteristics. Generic domestic raw materials easily trigger cascading issues including formula deterioration, production malfunctions and substandard finished product efficacy for mid-to-high-end overseas therapeutic pet food brands bound by EU regulations and prescription nutritional standards. Equipped with dual expertise in amino acid production and terminal formula development, HiSiaddi delivers two-way upstream and downstream technical optimization. This helps clients recover massive losses from scrapped finished products and achieve cost-effective procurement, while enabling domestic manufacturers to escape low-price competition and access high-end Nordic therapeutic raw material supply chains.
For more formula optimization consulting services, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
